Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology and risk factors
-
1. Epidemiology of COPD
- Dr. David Mannino
-
2. COPD in never smokers
- Dr. Sundeep Salvi
-
3. Genetics of chronic obstructive pulmonary disease (COPD)
- Prof. Martin Tobin
- Phenotypes of COPD
-
4. COPD and asthma: similarities and differences
- Prof. Peter Barnes
- Pathophysiology and mechanisms of COPD
-
5. The pathology of chronic obstructive pulmonary disease
- Prof. James Hogg
-
6. The continuum of COPD: a physiological perspective
- Prof. Denis O'Donnell
-
7. Inflammatory and immune mechanisms in COPD
- Prof. Peter Barnes
-
8. Mechanisms of COPD exacerbations and relation to exacerbation therapy
- Prof. Wisia Wedzicha
-
9. Protease-antiprotease balance
- Prof. Robert Stockley
- Therapy and management
-
10. Updates in chronic obstructive pulmonary disease (COPD)
- Dr. Omar S. Usmani
-
11. Long-acting bronchodilators in COPD
- Prof. Bart Celli
-
12. Treatment of COPD exacerbations
- Prof. Antonio Anzueto
-
13. Pulmonary rehabilitation: history, promise and problems
- Prof. Richard Casaburi
-
14. Lung volume reduction: advances in COPD
- Dr. Nick Hopkinson
-
15. New pharmacological therapies for COPD
- Prof. Peter Barnes
-
16. The Salford lung study in COPD
- Dr. Dave Leather
- COPD case studies
-
17. COPD treatment case I: COPD with “bronchitis attacks”
- Dr. Janwillem Kocks
-
18. COPD treatment case II: COPD with asthma as child
- Dr. Janwillem Kocks
-
19. COPD treatment case III: COPD with pre-diabetes
- Dr. Janwillem Kocks
-
20. Tailoring care for advanced COPD
- Prof. Wissam Chatila
- Archived Lectures *These may not cover the latest advances in the field
-
21. Alpha-1 antitrypsin deficiency: state of the art
- Dr. Jamie Stoller
-
22. Oxidative stress in COPD
- Prof. William MacNee
-
23. Managing co-morbidity in COPD
- Dr. John Hurst
-
24. Clinical phenotypes of COPD
- Prof. Jørgen Vestbo
-
25. Pulmonary rehabilitation: focusing on rehabilitative exercise
- Prof. Richard Casaburi
-
26. Genetics of COPD
- Prof. Ian Hall
Printable Handouts
Navigable Slide Index
- Introduction
- The case of Mrs. D
- The CCQ
- Mrs. D case continues
- Would you change your management?
- Manage stable COPD: goals of therapy
- Case management (non-pharmacological)
- GOLD guideline
- Case management (pharmacological)
- Manage stable COPD: pharmacologic therapy
- Pharmacological - device
- Case management (pharmacological) - conclusion
Topics Covered
- The clinical COPD questionnaire (CCQ) score
- Goals of COPD therapy
- GOLD guideline
- Case management
- An updated version, which will include the latest GOLD COPD recommendations, will be released in November 2017
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kocks, J. (2016, February 29). COPD treatment case I: COPD with “bronchitis attacks” [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/EKFW3810.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Janwillem Kocks has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology & Inflammation
Transcript
Please wait while the transcript is being prepared...
0:00
JANWILLEM KOCKS: Hi.
I'm Janwillem Kocks.
I'm a general practitioner and
researcher at the Department
of General Practice at
the University Medical Center
in Groningen.
This talk will be
about a COPD patient
with bronchitis attacks.
And this is the first of
a series of three cases
in which I will run through
the decision-making
on COPD patients
and management.
0:24
I would like to introduce
Mrs. D. and she's a 59-year-old lady.
And she works in
a community archive.
And during the annual
review for her COPD,
she tells you that it's
becoming more and more
difficult to carry the boxes
she has to carry for work
doing the last months.
And if you do
the lung function test,
you'll find a lung function
FEV1 of 74% of predicted,
and an FEV1/FVC ratio of 68%.
And actually, this has been
quite stable over the last years.
And she tells you she had
a course of antibiotics for one
of her bronchitis
attacks or lung attacks
during the last months when
in the weekend she had trouble,
and she went to
the out-of-hours GP service.
She's been smoking quite
a lot, of 35 pack years.
But she tells you very happily that
she stopped smoking four weeks ago.
And it was actually
the moment when she
was in trouble with her
coughing and breathlessness.
She's a bit overweight
with a BMI of 27.8.
And she has a CCQ score,
so a score on the questionnaire of 1.8.
I'll come back to that later on.
For the last years, she's been
using ipratropium bromide
as a dosis aerosol as needed.
And she tells you she's been
using that more and more lately.
At the moment, she's been using
it for about three times a day,
both at work and when she goes
out walking with her friends.
After the bronchitis attack,
for which she attended
the out-of-office service,
she received a prescription
of fluticason/salmeterol,
and she uses
that twice a day,
which is quite proactive
from the out-of-office GP.